Diagnostic strategy for growth hormone deficiency: relevance of IGF-1 determination as a screening test

Annales d'Endocrinologie

Volumn 68, Issue 6, 2007, Pages 449-455

  Hadjadj, S ^a   Faure Gerard, C ^a,b   Ragot, S ^a   Millet, C ^a   Duengler, F ^a   Torremocha, F ^a   Chatellier, G ^c   Bataille, B ^a   Marechaud, R ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Adult onset; Diagnostic strategy; GH; Growth hormone deficiency; IGF 1; ROC curve

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; BIOLOGICAL MARKER;

ADULT; ARTICLE; CELL FUNCTION; CONCENTRATION (PARAMETERS); COST; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE SECRETING CELL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN DETERMINATION; ROC CURVE; SCREENING TEST; TERTIARY HEALTH CARE; AGED; BLOOD; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; LABORATORY DIAGNOSIS; METABOLISM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL MARKERS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; GROWTH HORMONE; HUMANS; HYPOTHALAMIC DISEASES; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY DISEASES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 36749059467     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2007.08.004     Document Type: Article

References (30)

1. De Boer H., Blok G.J., and Van der Veen E.A. Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 16 (1995) 63-86
2. Amato G., Carella C., Fazio S., La Montagna G., Cittadini A., Sabatini D., et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. 77 (1993) 1671-1676
3. Jorgensen J.O., Pedersen S.A., Thuesen L., Jorgensen J., Ingemann-Hansen T., et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1 (1989) 1221-1225
4. Salomon F., Cuneo R.C., Hesp R., and Sonksen P.H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321 (1989) 1797-1803
5. Carroll P.V., Christ E.R., Bengtsson B.A., Carlsson L., Christiansen J.S., Clemmons D., et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin. Endocrinol. Metab. 83 (1998) 382-395
6. Hilding A., Hall K., Wivall-Helleryd I.L., Saaf M., Melin A.L., and Thoren M. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J. Clin. Endocrinol. Metab. 84 (1999) 2013-2019
7. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 379-381
8. Hoffman D.M., O'Sullivan A.J., Baxter R.C., and Ho K.K. Diagnosis of growth-hormone deficiency in adults. Lancet 343 (1994) 1064-1068
9. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann. Intern. Med. 138 (2003) 40-44
10. Hartman M.L., Crowe B.J., Biller B.M., Ho K.K., Clemmons D.R., and Chipman J.J. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?. J. Clin. Endocrinol. Metab. 87 (2002) 477-485
11. Sassolas G., Chazot F.B., Jaquet P., Bachelot I., Chanson P., Rudelli C.C., et al. GH deficiency in adults: an epidemiological approach. Eur. J. Endocrinol. 141 (1999) 595-600
12. Toogood A.A., Beardwell C.G., and Shalet S.M. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin. Endocrinol. (Oxf.) 41 (1994) 511-516
13. Attanasio A.F., Lamberts S.W., Matranga A.M., Birkett M.A., Bates P.C., Valk N.K., et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J. Clin. Endocrinol. Metab. 82 (1997) 82-88
14. Shalet S.M., Toogood A., Rahim A., and Brennan B.M. The diagnosis of growth hormone deficiency in children and adults. Endocr. Rev. 19 (1998) 203-223
15. Toogood A.A., O'Neill P.A., and Shalet S.M. Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J. Clin. Endocrinol. Metab. 81 (1996) 460-465
16. Aimaretti G., Corneli G., Razzore P., Bellone S., Baffoni C., Arvat E., et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J. Clin. Endocrinol. Metab. 83 (1998) 1615-1618
17. Popovic V., Leal A., Micic D., Koppeschaar H.P., Torres E., Paramo C., et al. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 356 (2000) 1137-1142
18. Aimaretti G., Baffoni C., DiVito L., Bellone S., Grottoli S., Maccario M., et al. Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur. J. Endocrinol. 142 (2000) 347-352
19. Aimaretti G., Corneli G., Baldelli R., Di Somma C., Gasco V., Durante C., et al. Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. Clin. Endocrinol. (Oxf.) 59 (2003) 56-61
20. Deyo R.A., and Jarvik J.J. New diagnostic tests: breakthrough approaches or expensive add-ons?. Ann. Intern. Med. 139 (2003) 950-951
21. Abrahamsen B., Nielsen T.L., Hangaard J., Gregersen G., Vahl N., Korsholm L., et al. Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency. Eur. J. Endocrinol. 150 (2004) 671-679
22. Murray R.D., Wieringa G.E., Lissett C.A., Darzy K.H., Smethurst L.E., and Shalet S.M. Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome. Clin. Endocrinol. (Oxf.) 56 (2002) 525-532
23. Ahmad A.M., Hopkins M.T., Thomas J., Ibrahim H., Fraser W.D., and Vora J.P. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement. Clin. Endocrinol. (Oxf.) 54 (2001) 709-717
24. Boquete H.R., Sobrado P.G., Fideleff H.L., Sequera A.M., Giaccio A.V., Suarez M.G., et al. Evaluation of diagnostic accuracy of insulin-like growth factor (IGF)-I and IGF-binding protein-3 in growth hormone-deficient children and adults using ROC plot analysis. J. Clin. Endocrinol. Metab. 88 (2003) 4702-4708
25. Cianfarani S., Boemi S., Spagnoli A., Cappa M., Argiro G., Vaccaro F., et al. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency?. Clin. Endocrinol. (Oxf.) 43 (1995) 43-47
26. Granada M.L., Murillo J., Lucas A., Salinas I., Llopis M.A., Castells I., et al. Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population. Eur. J. Endocrinol. 142 (2000) 243-253
27. Marzullo P., Di Somma C., Pratt K.L., Khosravi J., Diamandis A., Lombardi G., et al. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J. Clin. Endocrinol. Metab. 86 (2001) 3001-3008
28. Juul A., Moller S., Mosfeldt-Laursen E., Rasmussen M.H., Scheike T., Pedersen S.A., et al. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 4408-4415
29. Milani D., Carmichael J.D., Welkowitz J., Ferris S., Reitz R.E., Danoff A., et al. Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. J. Clin. Endocrinol. Metab. 89 (2004) 2271-2274
30. Mushlin A.I., Ruchlin H.S., and Callahan M.A. Costeffectiveness of diagnostic tests. Lancet 358 (2001) 1353-1355